IBB vs IEFA
iShares Biotechnology ETF vs iShares Core MSCI EAFE ETF
- • IEFA has the lower expense ratio at 0.07% vs 0.44% for IBB.
- • IEFA pays a higher dividend yield (3.42%).
Side-by-side metrics
| Metric | IBB | IEFA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.07% |
Dividend yield Trailing 12-month yield. | 0.16% | 3.42% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $189.30B |
YTD return | 30.22% | 10.97% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.88 |
P/E ratio | 25.48 | 17.13 |
Last price | $217.75 | $97.42 |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
IEFA top holdings
| ASML.AS | ASML Holding NV | 2.45% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.38% |
| SHEL.L | Shell PLC | 1.25% |
| NOVN.SW | Novartis AG Registered Shares | 1.19% |
| HSBA.L | HSBC Holdings PLC | 1.17% |
| AZN.L | AstraZeneca PLC | 1.13% |
| NESN.SW | Nestle SA | 1.06% |
| SAP.DE | SAP SE | 0.96% |
| 8306.T | Mitsubishi UFJ Financial Group Inc | 0.94% |
| SIE.DE | Siemens AG | 0.86% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About IEFA
IEFA (iShares Core MSCI EAFE ETF) is Developed-market equities ex-US/Canada. Managed by iShares, the fund carries $189.3B in assets under management, an expense ratio of 0.07%, a dividend yield of 3.42%. Its largest holding is ASML Holding NV (ASML.AS), which represents 2.5% of the portfolio. Real Estate is the fund's largest sector exposure at 2.7%.